Evidence map›Paper›PMID 29862119›Full record

ArticleJournal of analytical methods in chemistry2018

Screening and Characterizing Tyrosinase Inhibitors from

Ya-Li Wang, Guang Hu, Qian Zhang, Yu-Xiu Yang, Qiao-Qiao Li, Yuan-Jia Hu, Hua Chen, Feng-Qing Yang

Open access · goldAbstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Selecting and Characterizing Tyrosinase Inhibitors fromJournal of analytical methods in chemistry · 2021
    Article
  11. A comprehensive review on tyrosinase inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Ya-Li WangSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
Guang HuSchool of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.ORCID 0000-0003-3895-1744
Qian ZhangSchool of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China.
Yu-Xiu YangSchool of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China.
Qiao-Qiao LiSchool of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China.
Yuan-Jia HuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau.ORCID 0000-0001-5244-8577
Hua ChenSchool of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China.
Feng-Qing YangSchool of Chemistry and Chemical Engineering, Chongqing University, Chongqing 401331, China.ORCID 0000-0002-9300-5710
Chongqing University · CNChongqing University of Technology · CNUniversity of Macau · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinase (TYR) is a rate-limiting enzyme in the synthesis of melanin, while direct TYR inhibitors are a class of important clinical antimelanoma drugs. This study established a spectrum-effect relationship analysis method and high-performance liquid chromatography-mass spectrometry (LC-MS) analysis method to screen and identify the active ingredients that inhibited TYR in

Identifiers

PMID29862119
PMCPMC5971358
OpenAlexW2800673800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.